Wo finden aktuell Insiderkäufe statt?
Die folgende Übersicht zeigt die Summe der Aktienkäufe & -verkäufe von Insidern am offenen Markt. Sonstige Zuteilungen bspw. als Gehaltsbestandteil wurden bereits rausgefiltert.
Kostenlose Updates per Mail
USA
Unternehmen | Anz. Insider | Vol. Käufe | Vol. Verkäufe | Differenz |
---|---|---|---|---|
PRCIX | 1 | 254.081.610 $ | 0 $ | 254.081.610 $ |
Talis Biomedical | 8 | 106.224.000 $ | 0 $ | 106.224.000 $ |
Alphatec Holdings | 3 | 89.999.999 $ | 3.135.706 $ | 86.864.293 $ |
Decibel Therapeutics | 5 | 75.749.976 $ | 0 $ | 75.749.976 $ |
Vor Biopharma | 3 | 73.632.168 $ | 0 $ | 73.632.168 $ |
FDEQX | 1 | 65.100.925 $ | 0 $ | 65.100.925 $ |
Landos Biopharma | 2 | 45.813.240 $ | 0 $ | 45.813.240 $ |
Software Acquisition Group | 1 | 43.502.121 $ | 0 $ | 43.502.121 $ |
Bolt Biotherapeutics | 10 | 37.122.000 $ | 9.040 $ | 37.112.960 $ |
Terns Pharmaceuticals | 4 | 35.530.000 $ | 0 $ | 35.530.000 $ |
Fifth Wall Acquisition | 3 | 31.425.000 $ | 0 $ | 31.425.000 $ |
Butterfly Network | 1 | 25.000.000 $ | 0 $ | 25.000.000 $ |
NDAC | 2 | 20.700.000 $ | 0 $ | 20.700.000 $ |
Ironwood Pharmaceuticals | 8 | 20.633.780 $ | 809.377 $ | 19.824.403 $ |
Molecular Templates | 1 | 18.513.857 $ | 0 $ | 18.513.857 $ |
Prothena | 2 | 16.034.833 $ | 696.327 $ | 15.338.506 $ |
Power REIT | 5 | 13.171.561 $ | 0 $ | 13.171.561 $ |
Wayfair | 4 | 13.607.943 $ | 1.028.828 $ | 12.579.115 $ |
Exxon Mobil | 2 | 11.387.140 $ | 0 $ | 11.387.140 $ |
Corvus Pharmaceuticals | 3 | 9.349.998 $ | 0 $ | 9.349.998 $ |
FinServ Acquisition | 1 | 8.000.000 $ | 0 $ | 8.000.000 $ |
CFVI | 1 | 7.000.000 $ | 0 $ | 7.000.000 $ |
Satsuma Pharmaceuticals | 1 | 6.999.998 $ | 0 $ | 6.999.998 $ |
Mack-Cali Realty | 1 | 6.411.750 $ | 0 $ | 6.411.750 $ |
FSII | 1 | 6.025.000 $ | 0 $ | 6.025.000 $ |
GMS | 1 | 6.010.968 $ | 0 $ | 6.010.968 $ |
Oncorus | 1 | 5.700.000 $ | 0 $ | 5.700.000 $ |
Invesco Dynamic Credit Opportunities Fund | 1 | 5.617.418 $ | 0 $ | 5.617.418 $ |
Anterix | 9 | 7.248.122 $ | 1.761.006 $ | 5.487.116 $ |
FLME | 3 | 5.200.000 $ | 0 $ | 5.200.000 $ |
Teledyne Technologies | 3 | 4.842.702 $ | 0 $ | 4.842.702 $ |
TPG Pace Beneficial Finance | 1 | 4.669.120 $ | 0 $ | 4.669.120 $ |
PIMCO Energy and Tactical Credit Opportunities Fund | 1 | 4.644.900 $ | 0 $ | 4.644.900 $ |
NexImmune | 4 | 4.110.481 $ | 0 $ | 4.110.481 $ |
Agree Realty | 6 | 3.916.881 $ | 0 $ | 3.916.881 $ |
American Assets Trust | 1 | 3.870.236 $ | 0 $ | 3.870.236 $ |
Primo Water | 3 | 3.808.903 $ | 0 $ | 3.808.903 $ |
MACA | 1 | 3.528.570 $ | 0 $ | 3.528.570 $ |
TPG Pace Tech Opportunities | 1 | 3.430.818 $ | 0 $ | 3.430.818 $ |
Sensei Biotherapeutics | 2 | 3.021.350 $ | 0 $ | 3.021.350 $ |
Kaleido Biosciences | 2 | 2.702.501 $ | 0 $ | 2.702.501 $ |
OPKO Health | 1 | 2.383.455 $ | 0 $ | 2.383.455 $ |
Signify Health | 8 | 2.133.600 $ | 0 $ | 2.133.600 $ |
LGVN | 3 | 2.029.035 $ | 0 $ | 2.029.035 $ |
Cortexyme | 1 | 1.767.057 $ | 0 $ | 1.767.057 $ |
SLR Investment | 2 | 1.614.836 $ | 0 $ | 1.614.836 $ |
Dime Community Bancshares | 3 | 1.610.500 $ | 0 $ | 1.610.500 $ |
Franklin Street Properties | 3 | 1.553.141 $ | 0 $ | 1.553.141 $ |
ESSA Pharma | 1 | 1.539.000 $ | 0 $ | 1.539.000 $ |
Editas Medicine | 3 | 1.420.770 $ | 84.112 $ | 1.336.658 $ |
Alle Angaben ohne Gewähr! Keine Empfehlung/Beratung!